Leukocyte count is associated with incidence of coronary events, but not with stroke: A prospective cohort study

Atherosclerosis

Volumn 209, Issue 2, 2010, Pages 545-550

  Li, Cairu ^a   Engström, Gunnar ^a,b   Hedblad, Bo ^a  

^a LUND UNIVERSITY   (Sweden)

^b ASTRAZENECA R AND D   (Sweden)

Author keywords

Cohort study; Coronary events; Leukocyte count; Stroke

Indexed keywords

ADULT; AGE DISTRIBUTION; ALCOHOL CONSUMPTION; ARTICLE; BODY MASS; CARDIOVASCULAR DISEASE; CEREBROVASCULAR ACCIDENT; COHORT ANALYSIS; CONTROLLED STUDY; DIABETES MELLITUS; EVENT FREE SURVIVAL; FEMALE; FIBRINOGEN BLOOD LEVEL; FOLLOW UP; HUMAN; HYPERLIPIDEMIA; HYPERTENSION; INCIDENCE; ISCHEMIC HEART DISEASE; LEUKOCYTE COUNT; MAJOR CLINICAL STUDY; MALE; MIDDLE AGED; PHYSICAL ACTIVITY; PRIORITY JOURNAL; PROSPECTIVE STUDY; SEX DIFFERENCE; SMOKING; SWEDEN;

ADULT; CARDIOVASCULAR DISEASES; CORONARY DISEASE; FEMALE; FIBRINOGEN; HUMANS; INCIDENCE; LEUKOCYTE COUNT; MALE; MIDDLE AGED; PROSPECTIVE STUDIES; RISK FACTORS; SEX FACTORS; SMOKING; STROKE; SWEDEN;

EID: 77950021916     PISSN: 00219150     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.atherosclerosis.2009.09.029     Document Type: Article

References (25)

1. Libby P. Inflammation in atherosclerosis. Nature 2002, 420:868-874.
2. Hoffman M., Blum A., Baruch R., Kaplan E., Benjamin M. Leukocytes and coronary heart disease. Atherosclerosis 2004, 172:1-6.
3. Kannel W.B., Anderson K., Wilson P.W. White blood cell count and cardiovascular disease. Insights from the Framingham Study. JAMA 1992, 267:1253-1256.
4. Margolis K.L., Manson J.E., Greenland P., et al. Leukocyte count as a predictor of cardiovascular events and mortality in postmenopausal women: the Women's Health Initiative Observational Study. Arch Intern Med 2005, 165:500-508.
5. Madjid M., Awan I., Willerson J.T., Casscells S.W. Leukocyte count and coronary heart disease: implications for risk assessment. J Am Coll Cardiol 2004, 44:1945-1956.
6. Lee C.D., Folsom A.R., Nieto F.J., et al. White blood cell count and incidence of coronary heart disease and ischemic stroke and mortality from cardiovascular disease in African-American and White men and women: Atherosclerosis Risk in Communities Study. Am J Epidemiol 2001, 154:758-764.
7. Elkind M.S., Sciacca R.R., Boden-Albala B., et al. Relative elevation in baseline leukocyte count predicts first cerebral infarction. Neurology 2005, 64:2121-2125.
8. Danesh J., Wheeler J.G., Hirschfield G.M., et al. C-reactive protein and other circulating markers of inflammation in the prediction of coronary heart disease. N Engl J Med 2004, 350:1387-1397.
9. Sebastián-Gámbaro M.A., Lirón-Hernández F.J., Fuentes-Arderiu X. Intra- and inter-individual biological variability data bank. Eur J Clin Chem Clin Biochem 1997, 35:845-852.
10. Pankow J.S., Folsom A.R., Cushman M., et al. Familial and genetic determinants of systemic markers of inflammation: the NHLBI family heart study. Atherosclerosis 2001, 154:681-689.
11. Jenny N.S., Yanez N.D., Psaty B.M., et al. Inflammation biomarkers and near-term death in older men. Am J Epidemiol 2007, 165:684-695.
12. Pirro M., Bergeron J., Dagenais G.R., et al. Age and duration of follow-up as modulators of the risk for ischemic heart disease associated with high plasma C-reactive protein levels in men. Arch Intern Med 2001, 16:2474-2480.
13. Berglund G., Eriksson K.F., Israelsson B., et al. Cardiovascular risk groups and mortality in an urban Swedish male population. J Intern Med 1996, 239:489-497.
14. Lind P., Engström G., Stavenow L., et al. Risk of myocardial infarction and stroke in smokers is related to plasma levels of inflammation-sensitive proteins. Arterioscler Thromb Vasc Biol 2004, 24:577-582.
15. Kristenson H., Trell E. Indicators of alcohol consumption: comparisons between a questionnaire (Mm-MAST), interviews and serum gamma-glutamyl transferase (GGT) in a health survey of middle-aged males. Br J Addict 1982, 77:297-304.
16. The sixth report of the Joint National Committee on prevention, detection, evaluation, and treatment of high blood pressure. Arch Intern Med 1997;157:2413-46.
17. De Backer G., Ambrosioni E., Borch-Johnsen K., et al. European guidelines on cardiovascular disease prevention in clinical practice. Third Joint Task Force of European and other Societies on Cardiovascular Disease Prevention in Clinical Practice (constituted by representatives of eight societies and by invited experts). Atherosclerosis 2004, 173:381-391.
18. Engström G., Stavenow L., Hedblad B., et al. Inflammation-sensitive plasma proteins, diabetes, and mortality and incidence of myocardial infarction and stroke: a population-based study. Diabetes 2003, 52:442-447.
19. Laurell C.B. Electroimmuno assay. Scand J Clin Lab Invest 1972, (Suppl. 124):21-37.
20. The National board of Health and Welfare. Värdering av diagnoskvaliteten för akut hjärtinfarkt i patientregistret 1997 och 1995 (in Swedish). Stockholm, Sweden: Socialstyrelsen; 2000.
21. Jerntorp P., Berglund G. Stroke registry in Malmö. Stroke 1992, 23:357-361.
22. Schillaci G., Pirro M., Pucci G., et al. Prognostic value of elevated white blood cell count in hypertension. Am J Hypertens 2007, 20:364-369.
23. Wilhelmsen L., Köster M., Harmsen P., Lappas G. Differences between coronary disease and stroke in incidence, case fatality, and risk factors, but few differences in risk factors for fatal and non-fatal events. Eur Heart J 2005, 26:1916-1922.
24. Gillum R.F., Ingram D.D., Makuc D.M. White blood cell count and stroke incidence and death. The NHANES I epidemiologic follow-up study. Am J Epidemiol 1994, 139:894-902.
25. Rana J.S., Boekholdt S.M., Ridker P.M., et al. Differential leukocyte count and the risk of future coronary artery disease in healthy men and women: the EPIC-Norfolk Prospective Population Study. J Intern Med 2007, 262:678-689.